The beneficial androgenic action of steroidal aromatase inactivators in estrogen-dependent breast cancer after failure of nonsteroidal drugs

Direct treatment of ER (+) breast cancer with Formestane diminishes the tumor within weeks. This is unlikely due to lack of estrogens alone. We proposed that it is the negative influence of androgens on the growth of ER(+) breast cancer. We investigated the influence of Formestane and Exemestane and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Lanyang, Bao, Zheng, Deng, Heng, Li, Xiaofang, Li, Jiamin, Rong, Zuyuan, Yang, Youzhe, Liu, Ling, Nie, Dan, Wang, Guilin, Teichmann, Alexander T., Wieland, F. Heinrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591174/
https://www.ncbi.nlm.nih.gov/pubmed/31235695
http://dx.doi.org/10.1038/s41419-019-1724-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591174/
https://www.ncbi.nlm.nih.gov/pubmed/31235695
http://dx.doi.org/10.1038/s41419-019-1724-9

Ejemplares similares